CONMED Corporation
CNMDCONMED Corporation (CNMD) is a medical technology company that develops and manufactures surgical and patient monitoring products. Founded in 1970, it focuses on minimally invasive surgical solutions, orthopedics, and other medical devices used in various healthcare settings to improve patient outcomes.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| October 3, 2025 | $0.20 | 2025-09-15 | 2025-09-15 |
| July 3, 2025 | $0.20 | 2025-06-13 | 2025-06-13 |
| April 4, 2025 | $0.20 | 2025-03-14 | 2025-03-14 |
| January 3, 2025 | $0.20 | 2024-12-20 | 2024-12-20 |
| October 4, 2024 | $0.20 | 2024-09-16 | 2024-09-16 |
Dividends Summary
- Consistent Payer: CONMED Corporation has rewarded shareholders with 55 dividend payments over the past 13 years.
- Total Returned Value: Investors who held CNMD shares during this period received a total of $10.65 per share in dividend income.
- Latest Payout: The most recent dividend of $0.20/share was paid 112 days ago, on October 3, 2025.
- Yield & Schedule: CNMD currently pays dividends quarterly with an annual yield of 1.90%.
- Dividend Growth: Since 2012, the dividend payout has grown by 33.3%, from $0.15 to $0.20.
- Dividend Reliability: CNMD has maintained or increased its dividend for 55 consecutive payments.
Company News
The operating room equipment market is experiencing strong growth, driven by the increasing volume of surgical procedures and the growing incidence of chronic diseases, particularly among the aging population. North America is expected to dominate the market, with technological advancements and investments in research and development by key playe...
The global Wound Closure Market is expected to grow from $15.17 billion in 2023 to $26.63 billion by 2032, driven by increasing chronic wounds, aging population, and rising healthcare infrastructure. Sutures and hemostatic agents are the key product types, with general surgery and cardiology being the major application areas.
The global electrosurgery generators market is set for significant expansion, driven by the increasing adoption of minimally invasive surgical procedures and advancements in electrosurgical technologies. Radiofrequency generators are expected to gain strong traction, with the market projected to reach a valuation of USD 3,359.2 million by 2035.
The hip and knee reconstructive market is expected to grow significantly from 2025 to 2035, driven by technological advancements, an aging population, and the rising prevalence of orthopedic disorders. The market is projected to reach USD 41,071.4 million by 2035, with a CAGR of 5.6%.
The smoke evacuation system market is expected to grow significantly due to increased awareness of surgical smoke hazards, rising demand for minimally invasive procedures, and technological advancements in smoke evacuation devices.
